Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2010

View Archived Issues

Austrian scientists claim new antidiabetic agents

CalciMedica claims new calcium release-activated calcium channel protein inhibitors

NeuroSearch identifies new monoamine reuptake inhibitors

Piramal Life Sciences presents new diacylglycerol O-acyltransferase 1 inhibitors

Novel VEGFR-2 inhibitors presented by Hutchison MediPharma

Baxter reports on Vero cell-derived influenza vaccines

Booster dose of Japanese encephalitis vaccine Ixiaro enhances immunogenicity

Pentamycin effective against bacterial vaginosis

Persistent antibody response noted in adolescents 2 years after vaccination with Men ACWY

Valnoctamide demonstrates antimanic efficacy in double-blind trial

NAVIGATOR data on cardiovascular events and diabetes in at-risk patients presented

NCI-sponsored phase I/II trial of Spectrum's belinostat initiated in thymic malignancies

CytoDyn increases funds to accelerate Cytolin trial in HIV

FDA advisory committee: insufficient trial data on pixantrone in relapsed/refractory NHL

EMA's CHMP recommends new Kepivance label in Europe

FDA and EMA respond to GSK's report on rotavirus DNA in Rotarix vaccine

BioSante reports FDA orphan drug designation and phase II data for GVAX(R) leukemia vaccine

Novel selective M1 allosteric receptor modulators disclosed at ACS meeting

Clinical Data submits vilazodone NDA for major depressive disorder to FDA

EMA completes validation of InterMune's pirfenidone MAA for IPF

FDA approves Boehringer Ingelheim's once-daily Mirapex ER for Parkinson's disease

Garnet begins dosing in phase II trial of GBT-009 for improved scar appearance

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

Pain Therapeutics reports phase I clinical data on PTI-188 in skin cancer

Innate Immune and Cephalon Australia to collaborate to develop antibodies for asthma and SLE

Teva Pharmaceutical terminates license agreement with Antisense Therapeutics for ATL-1102

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...